Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 4 Results

Title
Intervention Indication Therapeutic Area Year Actions
Nintedanib in combination with Pemetrexed and Cisplatin for Unresectable Malignant Pleural Mesothelioma – first line Cisplatin (Platinol) , Nintedanib (Vargatef; Ofev; nintedanib esilate) , Pemetrexed (Alimta; pemetrexed ditromethamine dihydrate; pemetrexed ditrometamol; pemetrexed disodium) Malignant pleural mesothelioma (MPM) Lung and Respiratory Cancer 2018 View  |  Download
Nintedanib for treating interstitial lung disease in children aged 6 to 17 years old Nintedanib (Vargatef; Ofev; nintedanib esilate) Interstitial lung disease (ILD) Dermatology , Respiratory System 2022 View  |  Download
Nintedanib for Systemic Sclerosis Associated Interstitial Lung Disease Nintedanib (Vargatef; Ofev; nintedanib esilate) Interstitial lung disease (ILD) Dermatology , Respiratory System 2018 View  |  Download
Nintedanib for progressive fibrosing interstitial lung disease Nintedanib (Vargatef; Ofev; nintedanib esilate) Progressive fibrosing interstitial lung disease (PF-ILD) Respiratory System 2019 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications